A Phase I, Open-Label, Multicentre Study to Evaluate the Safety, Tolerability and Pharmacokinetics of MEDI4736 in Patients With Advanced Solid Tumours
Clinical trial NCT01938612 · COMPLETED
Trial details
- NCT number
- NCT01938612
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-12
- Primary completion
- 2018-03-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.